Press Releases

17 Oct 2025

NUH and NUS launch new Molecular Imaging and Theranostics Centre to strengthen patient care and research

The National University Hospital (NUH) and the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have jointly launched the Molecular Imaging and Theranostics Centre, a novel integrated clinical, education, research and development facility that brings together advanced diagnostics, targeted therapy and pioneering research. This landmark development is set to transform the way diseases such as cancer are diagnosed, treated and studied, positioning Singapore at the forefront of molecular imaging in Asia.

14 Oct 2025

Safer, more effective vaccines with new mRNA vaccine technology

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine technology that could make future vaccines safer, more effective, and less burdensome for patients.

13 Oct 2025

NUS Medicine launches new clinical trial centre to advance healthy longevity research

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), today launched a new Clinical Trial Centre under its Academy for Healthy Longevity, a pioneering hub to advance clinical research and catalyse educational excellence in precision geromedicine. Spanning 350 square meters, the new Centre is poised to enhance research capabilities and accelerate the clinical translation of geroscience into real-world solutions. Precision geromedicine entail

06 Oct 2025

Map of bacterial gene interactions reveals potential drug targets

Despite rapid advances in reading the genetic code of living organisms, scientists still face a major challenge today - knowing a gene’s sequence does not automatically reveal what it does. Even in simple, well-studied bacteria like Escherichia coli (better known as E. coli), about one-quarter of the genes have no known function. Traditional approaches—turning off one gene at a time and studying the effects—are slow, laborious, and sometimes inconclusive due to gene redundancy.

02 Oct 2025

NUS Medicine researchers develop fat-like nanoparticles to treat fatty liver disease

Researchers from NUS Medicine have developed a novel RNA-based therapy that could transform treatment for metabolic dysfunction-associated steatohepatitis (MASH), previously known as Non-alcoholic fatty liver disease (NAFLD), which affects approximately 25% of people worldwide, and up to 40% of adults in Singapore.

01 Oct 2025

NUS Medicine to receive S$2 million grant to boost infectious disease diagnostics across Asia

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) today announced a co-funded gift of S$2 million from the Novo Nordisk Foundation and Temasek Foundation to support a programme to enhance the diagnostics for severe bacterial infections and combat antimicrobial resistance (AMR), a deadly health issue in Asia.

30 Sep 2025

NUS Nursing and Lions Befrienders launch Singapore’s first large-scale intergenerational community dance programme to help seniors age well

Supported by research from the National University of Singapore (NUS) and a strong community partnership with Lions Befrienders, Singapore’s first large-scale dance programme for pre-frail and mildly frail seniors—to be rolled out at 10 Active Ageing Centres—advances Healthier SG and Age Well SG priorities for preventive, community-based care.

24 Sep 2025

Novel Nanovaccine halts tumour growth and reduces cancer recurrence

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and National Center for Nanoscience and Technology, the Chinese Academy of Sciences (CAS), have jointly developed an approach to significantly reduce the risk of cancer recurrence and metastasis after surgery, by targeting both bulk cancer cells and the elusive cancer stem cells (CSCs) responsible for relapse.

22 Sep 2025

Engineered gut bacteria improves survival outcomes in colorectal cancer tumours

In a new study that combines synthetic biology with cancer immunotherapy, researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Central South University in China have developed an engineered strain of gut-homing bacteria that stimulates potent antitumour immune responses against colorectal cancer (CRC).

19 Sep 2025

New NUS-MOH study: Singapore’s healthcare sector carbon emissions 18% lower than expected, a milestone in the city-state’s net zero journey

In a milestone for Southeast Asia’s healthcare sector, Singapore’s Ministry of Health (MOH), MOH Holdings Pte Ltd (MOHH), and the Centre for Sustainable Medicine (CoSM) at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have released its first-ever comprehensive national emissions report for Singapore’s healthcare sector, and the first comprehensive study across Asia.